KYMERA THERAPEUTICS, INC. Increase (Decrease) in Other Noncurrent Assets
KYMERA THERAPEUTICS, INC. (KYMR) reported Increase (Decrease) in Other Noncurrent Assets of -$1.73 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-05
- KYMERA THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2024-12-31 was $1.95M.
- KYMERA THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2024-09-30 was -$1.89M.
- KYMERA THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2023-12-31 was -$909.00K.
- KYMERA THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2023-09-30 was $0.00.
- KYMERA THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2025 was $7.16M.
- KYMERA THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2024 was -$168.00K.
- KYMERA THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2023 was -$909.00K, a 191.08% decline from fiscal 2022.
- KYMERA THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2022 was $998.00K, a 49.90% decline from fiscal 2021.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.73M 10-Q · filed 2026-08-05 | |||
| 2025-12-31 | $7.16M 10-K · filed 2026-02-26 | |||
| 2025-06-30 | $2.73M 10-Q · filed 2026-08-05 | |||
| 2024-12-31 | $1.95M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $59.00K derived: sum of 2 quarters · filed 2026-02-26 | -$168.00K 10-K · filed 2026-02-26 | |
| 2024-09-30 | -$1.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | -$2.12M 10-Q · filed 2024-10-31 | ||
| 2024-06-30 | -$227.00K 10-Q · filed 2024-08-07 | |||
| 2023-12-31 | -$909.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$909.00K derived: sum of 2 quarters · filed 2026-02-26 | -$909.00K 10-K · filed 2026-02-26 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $0.00 10-Q · filed 2024-10-31 | ||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-07 | |||
| 2022-12-31 | $998.00K 10-K · filed 2025-02-27 | |||
| 2021-12-31 | $1.99M 10-K · filed 2024-02-22 | |||
| 2020-12-31 | $30.00K 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |